Litcius/Paper detail

SGLT2 inhibitors may offer benefit beyond diabetes

Amy Kang, Meg Jardine

2020Nature Reviews Nephrology41 citationsDOI

Topics & Concepts

Diabetes mellitusMedicineType 2 diabetesType 2 Diabetes MellitusClinical trialIntensive care medicineInternal medicineEndocrinologyDiabetes Treatment and ManagementPotassium and Related DisordersMetabolism, Diabetes, and Cancer
SGLT2 inhibitors may offer benefit beyond diabetes | Litcius